clinical research boston

Participate in a clinical study and help make new treatments available

Select your area of interest:

Alzheimer’s

Fibromyalgia, obsessive compulsive disorder (ocd), male overactive bladder, adolescent migraine.

Boston Clinical Trials (BCT) is a multi-specialty clinical research center located in the Boston metro area. We conduct clinical studies in Dermatology, Gastroenterology, Internal Medicine, Neurology, Psychiatry, Sexual Dysfunction, and Urology. Whether you are a clinical trial sponsor, a prospective participant, or an industry professional, we invite you to learn more about us.

Boston Clinical Trials is  located in Roslindale near all public transportation. There’s free parking for those who drive. Evening appointments are available.

Therapeutic Areas

Years in Research

Studies Conducted

Clients & Partners

Be the first to learn about our new studies!

Further reading, don’t let summertime depression ruin your summer.

Summer time, and the livin’ is easy… right? Then why do you feel stressed, tired, and grumpy when your friends and co-workers […]

The History of Clinical Trials is Fascinating

For many of us working in clinical research or participating in the studies, the notion of testing new medications in statistically controlled, […]

The Seven “S” for Good Sleep

The link between depression and lack of good sleep is very well known. Scientists say that insomnia is not only a common […]

Master of Science in Clinical Research (MS)

Location: Boston, Online Start Term: Fall, Spring Gain the broad range of skills and connections you need to help bring breakthroughs in academic and industry laboratories to the world.

Equip Yourself to Guide Pioneering Research Toward Real-World Applications

Your 30-credit journey.

Our research-and-development focused curriculum prepares you to help carry scientific breakthroughs through the arduous process of product development, clinical trials, and regulatory management. Clinical research topics range from bioethics, regulations, product development, and biostatistics to research methodologies, protocol design, proposal development, clinical trial management, and regulatory affairs. You’ll also have the opportunity to develop specialized knowledge from dozens of elective courses.

Breakthroughs that Improve Outcomes

As a clinical research coordinator, you’ll oversee the complex process of translating fundamental research breakthroughs into real-world solutions.

Pharmaceutics students contribute to award-winning research 

Terrick Andey collaborated with Pharmaceutics master’s and PhD students to develop a novel nanoparticle delivery platform. Read Andey’s story.

$94k average salary

Clinical research scientist compensation reported by Salary.com in 2022.

Top Online Master's Programs as ranked by Online Master's Colleges.

A Global Hub for Clinical Research

MCPHS Community Voices

The lived experiences of MCPHS students, partners, and faculty tell an eloquent story. They illustrate just how our student-centered, teaching-first approach keeps us in the top tier of the country’s “most transformative colleges.” (Money magazine 2020).

Nicole LeBrecque

“When I was trying to decide which MCPHS program to apply to, the clinical research opportunities stood out to me. There’s a lot of new and upcoming research with PET scans and new PET tracers, and I enjoy being more hands-on.”

Students Publish with Pharmaceutical Sciences Professor

Graduate degrees in pharmaceutical sciences .

As well as the MS in Clinical Research, we offer five additional opportunities for graduate study at the master’s, doctoral, and certificate levels.

Master of Science in Medicinal Chemistry

Two-year, full-time program on the Boston campus.

Master of Science in Pharmaceutics

Two-year, full-time program on the Boston and Worcester campuses.

Graduate Certificate in Clinical Research

Flexible three-course program on the Boston campus and online.

Doctor of Philosophy in Medicinal Chemistry

Three-year, full-time program on the Boston campus.

Doctor of Philosophy in Pharmaceutics

50-credit, full-time program on the Boston and Worcester campuses.

Cookie Notice

Senior Clinical Research Associate

Research associates.

• 771 Albany Street, Boston, Massachusetts

Position: Senior Clinical Research Associate, OB/GYN        

Location: Boston, MA

Schedule: 40 hours per week, Hybrid

At Boston Medical Center (BMC), our diverse staff works together for one goal — to provide exceptional and equitable care to improve the health of the people of Boston. Our bold vision to transform health care is powered by our respect for our patients and our commitment to ensure everyone who comes through our doors has a positive experience.

You’ll find a supportive work environment at BMC, with rich opportunities throughout your career for training, development, and growth and where you’ll have the tools you need to take charge of your own practice environment.  

POSITION SUMMARY :

Develops pertinent background research, which contributes to a greater understanding of conditions, issues and trends impacting on a wide range of programs/projects, subjects and topics. Drafts background papers. Prepares preliminary outlines of projects to determine appropriate methodology, which may involve developing an historical perspective; identifying prevailing social and economic conditions, outlining legislative consideration; regulatory impact; international involvement in issues; and future trends and implications. Performs research and analysis. Documents and establishes files on all statistical analyses performed. Prepares data for use in summaries and fact sheets.

JOB RESPONSIBILITIES:

• Develops information sources. Reads, analyses, and evaluates data and literature. Prepares preliminary outlines of projects to determine appropriate methodology.
• Analyzes data developed and prepares written interpretations. Verifies references and checks facts of committee/expert panel reports.
• Performs research and analysis, analyzing and organizing technical data and reports and compiling summaries of information. May perform basic statistical research and analysis.
• Manages databases to track articles. Manages/maintains bibliographic and analytical databases. Documents and establishes files on all statistical analyses performed indicating methodology, variations in manipulation of data and resource material used.
• Writes technical papers or summaries. Abstracts information from scientific studies to create tables for committee/expert panel review or use in reports. Drafts, summarizes, and edits findings and provides feedback to the reviewers.
• Participates in selecting literatures for committee/expert panel members to receive through mailings, brief books, and committee/expert panel meetings. Attends committee/expert panel meetings to present and receive feedback regarding study area and prepares meeting summaries.
• Prepares the report for review and assists with review response. Creates bibliographies, graphics, and tables for reports.
• Serves as a mentor and/or resource to employees, May be responsible for training and supervising junior staff.

The above statements in this job description are intended to depict the general nature and level of work assigned to the employee(s) in this job.  The above is not intended to represent an exhaustive list of accountable duties and responsibilities required

JOB REQUIREMENTS

• Minimum education of a Master’s degree, preferably PhD Degree.

EXPERIENCE:

• At least five years of related professional experience preferred.
• Experience of leading and/or coordinating a team.
• Experience working in complex environments with a high degree of organizational effectiveness.

KNOWLEDGE AND SKILLS:

• Ability to solve intellectual problems of appreciable variety and complexity using originality and ingenuity.
• Ability to develop relationships with co-workers and employees in other divisions/departments/institutions through effective communication.
• Excellent written and oral skills with a proven ability to interact with all levels of employees.
• Computer literacy with Microsoft programs (Word, Excel, Access etc.) and Endnote.

JOB BENEFITS:

• Competitive pay
• Tuition reimbursement and tuition remission programs
• Highly subsidized medical, dental, and vision insurance options
• Career Advancement/Professional Development: Access a wealth of ongoing training and development opportunities that will not only enhance your skills but also expand your knowledge base especially for individuals pursuing careers in medicine or biomedical research.
• Pioneering Research: Engage in groundbreaking research projects that are driving the forefront of biomedical science.

ABOUT THE DEPARTMENT:

As the primary teaching hospital for Boston University Chobanian & Avedisian School of Medicine and BU schools of public health and dentistry, intellectual rigor shapes our inquiries. Our research is led by a belief that skin color, zip code, and financial circumstances shouldn’t dictate health.

Boston Medical Center is an Equal Opportunity/Affirmative Action Employer. If you need accommodation for any part of the application process because of a medical condition or disability, please send an e-mail to  [email protected]  or call 617-638-8582 to let us know the nature of your request.

Equal Opportunity Employer/Disabled/Veterans

Privacy policy

By clicking Submit, you acknowledge that you are willing to receive messages from Boston Medical Center relating to the status of your application or other recruitment related information to any mobile / cell phone number entered in the form above. You can easily opt-out of receiving messages by replying STOP to any messages you receive.

Not the right fit? Check out these other jobs

Respiratory therapist -$15k sign-on bonus, physical therapist, outpatient - $15k sign-on bonus, south bay, respiratory therapist-$15k sign-on bonus, physical therapist assistant - acute care, physical therapist, inpatient-$15k sign-on bonus, seiu service, refer a friend.

Your information:

Apply for this job now

EEO & Accommodation Statement Boston Medical Center is an equal employment/affirmative action employer. We ensure equal employment opportunities for all, without regard to race, color, religion, sex, national origin, age, disability, veteran status, sexual orientation, gender identity and/or expression or any other non-job-related characteristic. If you need accommodation for any part of the application process because of a medical condition or disability, please send an e-mail to [email protected] or call 617-638-8582 to let us know the nature of your request

E-Verify Program Boston Medical Center participates in the Electronic Employment Verification Program. As an E-Verify employer, prospective employees of BMC must complete a background check and receive medical clearance before beginning their employment at the hospital.

Federal Trade Commission Statement: According to the FTC, there has been a rise in employment offer scams. Our current job openings are listed on our website and applications are received only through our website. We do not ask or require downloads of any applications, or “apps” job offers are not extended over text messages or social media platforms. We do not ask individuals to purchase equipment for or prior to employment. To avoid becoming a victim of an employment offer scam, please follow these tips from the FTC: FTC Tips

Join the BMC Talent Community  

Before you go, don't forget to join our talent community!

We use cookies to make your interactions with our website more meaningful. They help us better understand how our websites are used, so we can tailor content for you. For more information about the different cookies we are using, read the Privacy Statement . By continuing to navigate the site, you agree to the use of cookies on our behalf.

• Current Students
• Admitted Students
• Alumni & Friends

BC.EDU LINKS

• Boston College
• Campus Life
• Jesuit, Catholic
• Academic Calendar
• BC Magazine
• Directories
• Offices, Services, Resources
• Agora Portal
• Maps & Directions
• Clinical Research Certificate
• Programs & Courses
• Clinical Aesthetics Injectables Certificate
• Fast Track Orientation and RN Refresher Certificate Program
• Clinical Spanish Certificate
• Clinical Skills
• Webinars & Online Courses
• Advanced Practice Courses
• Clinical Aesthetics Microneedling / Collagen Induction Therapy Training

Why Choose the Boston College Clinical Research Certificate Program?

• Gain an understanding of clinical research methodologies, regulations, and best practices. Equip yourself with the knowledge demanded by top pharmaceutical companies, research institutions, and healthcare organizations worldwide.
• Elevate your career prospects with a respected certificate.
• Learn from industry experts and accomplished professionals who bring real-world experience to the classroom. Benefit from their insights and guidance.
• Our program offers flexibility to suit your schedule. A varied live, online course schedule allows you to choose an iteration that works around your other commitments.
• Put theory into practice with practical exercises and case studies. Gain a broad perspective of clinical trials, collecting data, and analyzing results to prepare for your career as a clinical research professional.
• Connect with fellow students, alumni, and industry experts. Build a powerful professional network.

Whether you aspire to  become a Clinical Research Associate, Clinical Trial Coordinator, Regulatory Affairs Specialist, or Clinical Data Manager, our Clinical Research Certificate program will empower you with the knowledge and skills to excel in this dynamic and vital field.

This certificate program consists of three courses that will provide you with the tools you need to become successful in today's rigorous marketplace.

Clinical Research: Principles, Protocols and Procedures

Project management in clinical research.

• Career Pathways in Clinical Research

Each session is taught by an instructor currently working in that topic area. They work at organizations including: Boston Children’s Hospital, Centrexion Therapeutics, Deciphera Pharmaceuticals, EMD Serono, Inc., EndPointe Clinical Resources, Inc, Harvard T.H. Chan School of Public Health, ImmunoGen, Inc., Johnson & Johnson (Janssen Oncology), Medidata, Merck, Propel Careers, QurAlis, Takeda Pharmaceuticals International Co., Valerio Therapeutics

See Course Descriptions and Times in the Tabs Below

Register for Spring 2024 Courses

Register for Fall 2024 and Winter/Spring 2025 Courses

Sign Up for the Next Info Session: Wednesday, April 17 2024, 6 pm ET

Join Our Mailing List

• CLINICAL RESEARCH: PRINCIPLES, PROTOCOLS AND PROCEDURES
• PROJECT MANAGEMENT IN CLINICAL RESEARCH
• CAREER PATHWAYS IN CLINICAL RESEARCH

The content of this course is designed to provide a thorough overview of clinical research conduct, the drug development process, the roles of the Clinical Research Associate and Clinical Research Coordinator, and other key roles in the conduct of clinical research.

This course meets for 10, three hour sessions: Session 1: Overview of the Clinical Research Process Session 2:  Clinical Research Personnel, Service Providers, and the Site Selection Process Session 3: Human Subject Protections and Regulatory Oversight Session 4: Clinical Trial Conduct, Monitoring and Record Keeping Session 5: Components of Ethical Evaluation of Human Research and Privacy Considerations Session 6: Recruitment and Retention, Drug Compliance and Accountability, and Study Close-Out Procedures Session 7:  Pharmacovigilance in Drug/Device Development Session 8:  Audits & Inspections: Ensuring Clinical Research Quality Session 9:  The Role of Data Management in Clinical Research Session 10:  Study Budgets and Contracts: Evaluation and Negotiation

$1899 (includes $75 book fee)

Thursdays, September 19 to November 21, 2024 6:00 - 9:00 PM ET

Register for Fall 2024 Session

Saturdays, February 15 to March 15, 2025 9:00 AM - 3:30 PM*

* Two sessions per day with a 30 minute break in between. (9:00 - 12:00 and 12:30 - 3:30)

Register for Winter 2025 Session

Tuesdays and Thursdays, May 6 to June 5, 2025 6:00 - 9:00 PM

Register for Spring 2025 Session

This course will provide an overview of the project management processes: initiation, planning, project life cycle, effective team building, execution, monitoring, tracking, risk management, change management, contingency planning, and close-out processes and procedures.

This course will benefit professionals interested in pursuing a clinical research career by providing a clear understanding of project management principles and processes.Learn industry trends and best practices through real-world examples involving team projects and case studies presented by experts in the industry. Through discussion, presentation, and interaction, this course will broaden the participants' knowledge of the project management process in clinical research.

Tuesdays and Thursdays, June 11, 13, 18, & 20, 2024 6:00 - 9:00 PM

Register for Spring 2024 Session

________________________________________________

Tuesdays, October 1, 8, 15  & 22, 2024 6:00 - 9:00 PM

Saturdays, March 29, April 5 & 12, 2025 9:00 AM - 1:00 PM

Tuesdays and Thursdays, June 10, 12, 17, & 19, 2025 6:00 - 9:00 PM

Career Pathways Clinical Research

This course deals with the challenges related to managing change associated with career transition. Understand the clinical research field as well as your career strengths, career interests, and values. In addition, focus on your uniqueness and its value to yourself and the marketplace. Identify transferable skills and accomplishments that can be used in clinical research. Learn from clinical research experts how to market yourself and how to enter the clinical research arena.

This course is presented in two sessions that will prepare you to confidently embark on your job search. 

Session 1: Computerized Systems in Clinical Research Clinical Trial Management System Software Review of Clinical Trials

• Electronic Data Capture (EDC)
• Clinical Trial Management Systems (CTMS)
• Risk Based Monitoring (RBM)

Session 2: Transitioning into and Growing a Career in Clinical Research Résumé Basics, Job Search Strategies, and Internet Marketing

• Overview of clinical research roles 
• Tips to structure a job search 
• Résumé tips Informational interviewing to accelerate a search
• Social media tools (LinkedIn) for your search 
• Networking 

Monday April 29 & Wednesday, May 1, 2024, 6:00 – 9:00 PM

Register for Spring 2024

Tuesday, June 24 & Thursday, June 26, 2025 6:00 - 9:00 PM

Register for Spring 2025

Tuesday, June 25 & Thursday, June 27, 2024 6:00 - 9:00 PM

Tuesdays, November 5 & 12, 2024 6:00 - 9:00 PM

Register for Fall 2024

Mondays, April 28 & 30, 2025 6:00 - 9:00 PM

Register for Winter 2025

These multidisciplinary courses have been designed for professionals interested in moving into the field of pharmaceutical/clinical research. Hospitals and pharmaceutical companies seek out nurses or people with a science background for these roles because they have a scientific knowledge base, good interpersonal skills, and experience working with physicians and other nurses. Participants also use this certificate program as a refresher or as a review for certification examination.This certificate program provides you with the tools you need to become successful in today's rigorous marketplace. All topics can be completed in less than two semesters. To earn a certificate, a student must successfully complete all of the required courses within a two-year period. In order to receive contact hours, participants must attend the course and complete the examinations.

617-552-4256

Sonce@bc.edu.

281-517-0550

[email protected]

For Inquiries:

Dm clinical.

Advancing medicine through innovation and dedication.

Boston University Academics

Boston University

• Campus Life
• Schools & Colleges
• Degree Programs
• Search Academics
• Online Graduate Certificate Program in Clinical Research

For contact information, please visit the Graduate Medical Sciences website .

Clinical research is the fastest-growing discipline in the burgeoning medical device and pharmaceutical industries. Keeping pace with the ever-increasing body of knowledge and new regulatory procedures generated by advances in clinical research is critical to career success. The Boston University Online Graduate Certificate in Clinical Research, designed and offered by the BU Chobanian & Avedisian School of Medicine , is an opportunity for clinical researchers, health professionals, and those interested in clinical research to gain a critical understanding of the scientific fundamentals of human research. Courses in the curriculum provide an in-depth look at a number of the key elements in clinical investigation, including: trial design and conduct, clinical research regulations, good clinical practices of research, and the critical evaluation of clinical research in the medical literature. The program can be completed in one year, across two semesters. We accept applications for both September and January start dates.

Learning Outcomes

At the completion of this program, students will be able to:

• Demonstrate the ability to design a clinical research protocol.
• Demonstrate the ability to read and critique the clinical research literature.
• Demonstrate the ability to interpret and apply the research regulations, and practices that guide good clinical practice in clinical research.

Upon completion, students will have developed essential skills and understanding involving the elements and importance of good clinical research design, implementation, and practices. Clinical and health professionals of all varieties—including physicians; research nurses; study coordinators; managers in clinical research and site management; and professionals in the pharmaceutical, biotechnology, and medical device industries as well as CRO and SMO organizations—will benefit from this opportunity to:

• Earn a graduate certificate from the  Chobanian & Avedisian SOM , a leading research institution
• Complete a valuable professional credential in just two to four full semesters of study
• Increase skills and knowledge in clinical research
• Apply a portion of the credits (up to 8 credits) toward the MSCR degree
• Qualify to sit for the Association of Clinical Research Professionals (ACRP) Clinical Research Coordinator (CRC) exam

Program Requirements

The certificate program consists of four online courses:

Fall Semester

• GMS CI 660 OL Good Clinical Practices (4 cr)
• GMS CI 675 OL Designing Clinical Research Studies (4 cr)

Spring Semester

• GMS CI 640 OL Regulatory and Compliance Issues (4 cr)
• GMS CI 789 OL Critical Evaluation of the Medical Literature (4 cr)

Related Bulletin Pages

• Graduate Medical Sciences Courses
• Abbreviations and Symbols

Beyond the Bulletin

• GMS Admissions
• Financial Assistance
• The Vesalius Certificate
• Anatomy & Neurobiology
• Behavioral Neuroscience
• Biochemistry
• MD/PhD in Bioinformatics
• Biomedical Forensic Sciences
• Biomedical Research Technologies
• Biomedical Sciences (PiBS)
• MS in Clinical Research
• Dual MS in Medical Sciences and Clinical Research
• MD/MS in Clinical Research
• Hybrid Graduate Certificate Program in Clinical Research
• Forensic Anthropology
• Genetic Counseling
• Genetics & Genomics
• Health Care Emergency Management
• Health Professions Education
• Medical Anthropology & Cross-Cultural Practice
• Medical Sciences
• Mental Health Counseling & Behavioral Medicine Program
• Microbiology
• Molecular & Translational Medicine
• Neuroscience
• Nutrition & Metabolism
• Oral Biology
• Oral Health Sciences
• Pathology & Laboratory Medicine
• Pharmacology & Experimental Therapeutics
• Physician Assistant
• Physiology or Biophysics
• Departments
• BU Medical Campus Library
• Graduate Medical Sciences Student Organization (GMSSO)

Terms of Use

Note that this information may change at any time. Read the full terms of use .

related websites

• Graduate Medical Sciences

Accreditation

Boston University is accredited by the New England Commission of Higher Education (NECHE).

• © Copyright
• Mobile Version

Ready to start planning your care?  Call us at 800-525-2225 to make an appointment.

Let's get started

• New patient
• Current patient
• New York City
• New York State
• Acoustic Neuroma
• Carcinomas and Other Rare Solid Tumors in Children
• Anal Cancer
• Adrenal Tumors
• AIDS-Associated Cancers
• Appendiceal Cancer
• Basal Cell Carcinoma
• Bladder Cancer
• Benign Blood Disorders
• Bone Cancer
• Brain Tumors, Metastatic
• Brain Tumors, Primary
• Breast Cancer
• Breast Cancer, Male
• Cancer of Unknown Primary Origin
• Central Nervous System (CNS) Lymphoma
• Cervical Cancer
• Colon Cancer
• Desmoplastic Small Round Cell Tumor
• Esophageal Cancer
• Ewing Sarcoma
• Gallbladder & Bile Duct Cancers
• Gastrointestinal Neuroendocrine Tumors
• Gestational Trophoblastic Disease
• Glioblastoma
• Graft-Versus-Host Disease (GVHD)
• Head & Neck Cancers
• Histiocytosis
• Kaposi Sarcoma
• Kidney Cancer
• Hematologic Oncology
• Liver Cancer
• Liver Metastases (Secondary Liver Cancer)
• Low-Grade Glioma
• Lung Cancer
• Merkel Cell Carcinoma
• Mesothelioma
• Mouth Cancer
• Multiple Myeloma
• Myelodysplastic Syndrome
• Neuroblastoma
• Neurofibromatosis
• Osteosarcoma
• Ovarian Cancer
• Pancreatic Cancer
• Pancreatic Cysts
• Pediatric Blood Disorders
• Pediatric Brain Tumors
• Pediatric Leukemias
• Pediatric Lymphomas
• Pediatric Sarcomas
• Pediatric Cancer Care
• Pituitary Tumors
• Prostate Cancer
• Pulmonary Neuroendocrine Tumors
• Rare Blood Disorders
• Retinoblastoma
• Rectal Cancer
• Rhabdomyosarcoma
• Salivary Gland
• Skin Cancer
• Soft Tissue Sarcoma
• Spine Tumors
• Squamous Cell Carcinoma
• Stomach (Gastric) Cancer
• Testicular Cancer (Germ Cell Tumors)
• Throat Cancer
• Thymoma & Other Thymic Tumors
• Thyroid Cancer
• Tracheal Diseases
• Uterine (Endometrial) Cancer
• Uterine Sarcoma
• Wilms' Tumor

MSK has ranked in the top two “Best Hospitals for Cancer” every year since U.S. News & World Report began rating hospitals in 1990.

Many treatments and services are available at locations across NY and NJ.

Get care from the comfort of your home with telemedicine from MSK.

Our doctors and scientists work together so patients get access to cutting-edge treatments as soon as they are available.

Find a trial

Giovanna Whitting’s metastatic thyroid cancer was not responding to standard treatments. Then, an innovative database developed at MSK changed the trajectory of her care.

Support the essential work of our doctors, nurses, researchers and staff, so MSK can provide access to world-class, compassionate care for people with cancer.  

BMC’s Yawkey building doors are now closed as an entrance as part of our ongoing efforts to enhance our campus and provide you with the best clinical care.

All patients and visitors on our main campus must enter our hospital via Shapiro, Menino, or Moakley buildings, where they will be greeted by team members at a new centralized check-in desk before continuing to the hospital. We are excited to welcome you and appreciate your patience as we improve our facilities.

Utility Menu

• Request an Appointment

Popular Searches

• Adult Primary Care
• Orthopedic Surgery

Participate in Research or Clinical Trials

Select your language:

Learn more general information about participating in research at  BUMC  and BMC .

If you have any questions or do not see the study you are interested in, please contact the Clinical Trial Office at [email protected] .

If you are interested in participating a clinical trial, see the Study Finder .

• Find a Doctor
• Appointments and Second Opinions
• Find a Location
• Patient Portals

Clinical trials show promise in treating central nervous system lymphoma, breast cancer, and glioblastoma

The findings to be presented at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO).

Dana-Farber Cancer Institute researchers are leading 3 separate studies with encouraging results in treating patients with central nervous system (CNS) lymphoma, breast cancer, and glioblastoma. The studies support future research in these potential breakthroughs where treatment options may be limited. The research teams will present their findings at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 31-June 4, 2024. ASCO is the world's largest clinical cancer research meeting, attracting more than 30,000 global oncology professionals.

These findings are among more than 80 studies presented at ASCO that are led by Dana-Farber-affiliated researchers.

A full list of Dana-Farber Oral Presentations at the 2024 ASCO Annual Meeting is available here.

A full list of Dana-Farber Poster Discussions at the 2024 ASCO Annual Meeting is available here.

CAR T-cell therapy shows promise in patients with central nervous system lymphoma

A CAR T-cell therapy approved for patients with large B cell lymphoma has produced positive results in a pilot study involving patients with relapsed, treatment-resistant central nervous system (CNS) lymphoma, Dana-Farber investigators report. The therapy, axicabtagene ciloleucel, was found to be safe and well tolerated in the 18 study participants and had an overall response rate of 94%. The median progression-free survival – the time in which patients lived without the cancer worsening – was 14.3 months, and the median overall survival was 26.4 months. The most common side effects, cytokine release syndrome and immune effector cell-associated neurologic syndrome (ICANS) that are inflammatory conditions often associated with CAR T-cell therapy, were manageable. CNS lymphoma is a rare non-Hodgkin lymphoma in which malignant cells form in the lymph tissue of the brain or spinal cord. Although initial treatment is often effective, better treatments are needed when the disease recurs. CAR T-cell therapies use genetically modified versions of a patient's own immune system T cells to attack cancer cells in the body.

• Study Title: A Pilot Study of Axicabtagene Ciloleucel (axi-cel) for Relapsed/Refractory Primary and Secondary Central Nervous System Lymphoma Oral Abstract Number: 2006 Session: Oral Abstract Session - Central Nervous Tumors; June 3, 2024, 10:36am ET Presenting & Lead Author: Lakshmi Nayak, MD Co-lead Author: Caron Jacobson, MD, MMSc

Antibody-drug conjugate plus checkpoint inhibitor shows a trend toward improved progression-free survival in PD-L1-positive hormone receptor-positive, HER2-negative breast cancer

In patients with metastatic hormone receptor (HR)-positive/HER2-negative breast cancer unselected by PD-L1 status, adding the immune checkpoint inhibitor pembrolizumab to the antibody-drug conjugate sacituzumab govitecan resulted in a 1.9-month improvement in median progression-free survival that was not statistically significant. In the subgroup of patients with PD-L1-positive tumors (defined as a combined positive score ≥1), a 4.4-month increase in median progression-free survival was observed with sacituzumab govitecan plus pembrolizumab compared to sacituzumab govitecan alone.

The phase II SACI-IO HR+ trial was designed to evaluate whether these two therapies act synergistically. Sacituzumab govitecan consists of an antibody linked to a chemotherapy drug called SN-38. In cancer cells, SN-38 causes DNA damage that, via activation of pathways in the cancer cell, may draw T-cells to the cancer. The combination with pembrolizumab (an immune checkpoint inhibitor that lifts the brakes off the immune system) could enhance the ability of the immune system to recognize and attack cancer cells. The SACI-IO HR+ trial included 110 patients with previously treated advanced or metastatic HR-positive/HER2-negative breast cancer; 104 patients started therapy on the study – half of whom received sacituzumab govitecan plus pembrolizumab and half of whom received sacituzumab govitecan alone.

At a median follow-up of 12.5 months, the median progression-free survival (how long patients lived before their cancer worsened) was 8.1 months for patients receiving the combined therapy, compared to 6.2 months for those receiving sacituzumab govitecan alone. In the approximately 40% of patients who participated in the study whose tumor was PD-L1-positive, the median progression-free survival was 11.1 months with the combination vs 6.7 months with sacituzumab govitecan alone. These results support further investigation of sacituzumab govitecan plus pembrolizumab in patients with PD-L1-positive metastatic HR-positive/HER2-negative breast cancer.

• Study Title: SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer Abstract Number: LBA1004 Session: Oral Abstract Session - Breast Cancer Metastatic; June 1, 2024, 5:00pm ET Presenting Author: Ana Garrido-Castro, MD Senior Author: Sara Tolaney, MD, MPH

Drug targeting protein involved in control of immune response produces encouraging results in glioblastoma

A drug that targets a protein involved in regulating the immune response might be promising in patients with glioblastoma, Dana-Farber investigators report. The drug ibudilast inhibits a protein called MIF, which is produced at elevated levels in patients with glioblastoma and can hamper the immune response to cancer. In a phase 1b/2a study, 36 patients with newly diagnosed glioblastoma and 26 patients with recurrent glioblastoma were treated with daily ibudilast and monthly cycles of temozolomide, a chemotherapy agent. The six-month progression-free survival was 44% for patients with newly diagnosed glioblastoma and 31% for those with recurrent glioblastoma. Although the survival rates were comparable to historically reported rates, laboratory research suggests the drug may be more effective in patients with glioblastoma when combined with immunotherapy agents known as checkpoint inhibitors, making this combination a potentially promising therapy.

• Study Title: Phase 1b/2a study evaluating the combination of MN-166 (Ibudilast) and temozolomide in patients with newly diagnosed and recurrent glioblastoma Oral Abstract Number: 2016 Session: Rapid Oral Abstract Session - Central Nervous System Tumors; June 2, 2024, 1:00pm ET Presenting Author: Gilbert Youssef, MD Senior Author: Patrick Wen, MD

ASCO Awards and Fellows

ASCO recognized Janet L. Abrahm, MD, FACP, FAAHPM, of Dana-Farber and Brigham and Women's Hospital, as a recipient of an ASCO Special Award, the Society's highest honor. Abrahm was awarded the Walther Cancer Foundation Supportive Oncology Award, noting her as a distinguished leader in palliative and supportive oncology through the prevention, assessment, and management of cancer- and treatment-related suffering.

Each year ASCO also recognizes members with the Fellow of the American Society of Clinical Oncology (FASCO) distinction. This year Narjust Florez, MD, FASCO, and Shail Maingi, MD, FASCO, are among the recipients recognized for their extraordinary volunteer service, dedication, and commitment to ASCO.

For all ASCO-related media inquiries, call, or email Victoria Warren, 617-939-5531 , [email protected] . Follow the meeting live on X using the hashtag #ASCO24 and follow Dana-Farber News on X at @DanaFarberNews.  

Media Contacts

If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email [email protected] .

The Media Team cannot respond to patient inquiries. For more information, please see Contact Us .

Dana-Farber Cancer Institute research presented at ASCO 2024.

Center for Retirement Research Partners with UMass Boston

Squared Away Blog by Kimberly Blanton

To bring a broader perspective to issues affecting retirement and aging, the Center for Retirement Research (CRR) at Boston College is working with the Gerontology Institute and other researchers at the University of Massachusetts Boston.

The five-year arrangement is supporting research projects by UMass Boston researchers in collaboration with CRR and is funding summer research fellowships for UMass Boston undergraduates.

“UMass Boston’s expertise in qualitative research techniques such as focus groups infuse their work with the perspectives of underserved communities,” said Andrew Eschtruth, deputy director of CRR, which also supports this blog.

The partnership’s activities are funded by the U.S. Social Security Administration. The collaboration with UMass Boston, Eschtruth said, fits with the agency’s goal of broadening the network of researchers and students it supports. UMass Boston has deep connections with underserved communities in the Boston metropolitan area and beyond, and it serves a large population of students of color and first-generation students.

“Our expertise in areas such as financial security and long-term care costs complement the center’s focus,” said Jan Mutchler, director of the Gerontology Institute. “As a minority-serving institution, we especially value opportunities for our students to gain research experience and professional development through paid fellowships.”

Two joint research projects funded this year by Social Security are exploring how to  improve communication  about the agency’s benefits in the Black and Hispanic communities and the types of services that would  provide the most support  to caregivers based on their personal needs and preferences.

CRR is one of six research centers in Social Security’s Retirement and Disability Research Consortium. UMass Boston joins three other CRR affiliates: Syracuse University, the Urban Institute, and the Mathematica Center for Studying Disability Policy.  

Squared Away  writer Kim Blanton invites you to follow us  @SquaredAwayBC on X, formerly known as Twitter. To stay current on our blog, join  our free email list. You’ll receive just one email each week – with links to the two new posts for that week – when you  sign up here .  This blog is supported by the Center for Retirement Research at Boston College.

I hope that UMass Boston will be careful to ensure their focus group participants are representative of populations of interest. Going to a church or community based organization and rounding up the first 100 willing people more or less guarantees an unrepresentative sample – most people bowl alone and have nothing to do with such organizations. But the approach suits those who choose to define individuals by reference to an assumed group identity.

Leave a comment Cancel reply

Your email address will not be published. Required fields are marked *. The Center for Retirement Research does not post all comments and may edit some for clarity or brevity. For more details on our reader comments policy, see here .

Retiree Living Standards, Ranked by State

Why Is This High-Income State’s Elderly Population Struggling Financially?

MarketWatch Blog by Alicia H. Munnell

How Did the Expansion of Vocational Rehabilitation Services Affect Youth Receiving SSI?

Working Paper by Isabel Musse , Todd Honeycutt , and Jeffrey Hemmeter

Privacy Overview

• Claim credits
• Plan your learning
• Browse journals and articles
• View sessions recordings
• Renew membership
• Submit Your Science!
• Find other members
• Become a member leader
• Get published
• Earn recognition
• Develop your career
• Promote your work

Advancing endocrinology and improving public health

Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field. 

ENDO 2024: It’s a Wrap! Claim Certificates of Attendance, Credits, More

June 05, 2024

ENDO 2024 has come to a successful conclusion. To claim Continuing Medical Education (CME) credits and Maintenance of Certification points, please follow these steps: (1) Log into education.endocrine.org; (2) Select “My Courses” from the left side menu; (3) Find ENDO 2024 and select “Start Course” to launch the evaluation. Upon completion of the evaluation, you can claim credits based on your credit preferences set up at the time you first accessed education.endocrine.org. All registrants must finalize claims by Wednesday, August 7, 2024.

2025 Call for Nominations for Board of Directors

June 04, 2024

We are seeking dedicated members who embody the Board core competencies to lead our organization into the future. If you or a colleague are passionate about the field of endocrinology, are familiar with the Society, and want to join the team who will drive our strategy forward, review our open positions and submit a nomination by Friday, August 2, 2024.

Unlock Your Clinical Expertise: Register Now for CEU & EBR 2024

April 23, 2024

Registration is now open for Clinical Endocrinology Update (CEU) 2024 on September 19-21, and Endocrine Board Review (EBR) 2024 on September 6-8. Join us to stay at the forefront of endocrinology advancements, and gain access to the latest recommendations in hormone care. Elevate your expertise and prepare for the American Board of Internal Medicine's (ABIM) Endocrinology, Diabetes, and Metabolism Certification Exam with confidence. Register by August 5 for the lowest rates.

Just Released: 2024 Endocrine Case Management: Meet the Professor

May 31, 2024

Stay ahead in your practice with the latest insights and real-world cases presented in 2024 Endocrine Case Management: Meet the Professor. This comprehensive resource includes 40 cases covering various endocrine disorders, featuring contributions from 57 leading experts across 11 subspecialties. This resource is certified for 30.0 AMA PRA Category 1 Credits™. Order yours today!

Advocacy in Action

Read about our advocacy accomplishments in our special "ENDO" edition of Advocacy in Action.

We Are Endocrinology

Advantages of Membership

For career advancement.

• Publish with Us
• Gain professional recognition
• Attend a meeting or event
• Share your story

For Continuing Education

• Learn and claim credits (CME/MOC)
• Explore career development resources
• View session recordings

Need more info?

Endocrine Society News

Endocrine society guideline recommends healthy adults under the age of 75 take the recommended daily allowance of vitamin d.

June 03, 2024

Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require testing for vitamin D levels, according to a new Clinical Practice Guideline issued today by the Endocrine Society. For children, pregnant people, adults older than 75 years and adults with high-risk prediabetes, the guideline recommends vitamin D higher than the IOM recommended daily allowance.

Meditating with headband that tracks brain activity may improve surgical recovery in patients with Cushing’s

Patients with Cushing’s syndrome who are recovering from surgery and wear a headband that tracks brain activity while they meditate may have less pain and better physical functioning compared with patients not using the device, suggests a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Type of weight loss surgery women undergo before pregnancy may influence children’s weight gain

The type of weight loss surgery women undergo before becoming pregnant may affect how much weight their children gain in the first three years of life, suggests a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Featured Journal Articles

Spontaneous adrenal hemorrhage in a pregnant woman with glucocorticoid resistance syndrome.

The authors report a 27-year-old woman with a 10-year history of hypertension who presented with hypokalemic paresis. She had regular menses and acne but was not cushingoid.

Mathematical Models of the Effect of Glucagon on Glycemia in Individuals With Type 2 Diabetes Treated With Dapagliflozin

We investigate the roles of insulin and glucagon in the regulation of glycemia in individuals treated with a sodium-glucose cotransporter 2 inhibitor using mathematical model analysis.

β-Cell Insulin Resistance Plays a Causal Role in Fat-Induced β-Cell Dysfunction In Vitro and In Vivo

We hypothesize that upregulation of insulin signaling would protect against β-cell dysfunction specifically induced by fat.

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history  and how we continue to serve the endocrine community.

Clinical Research Resources Office

loading slideshow...

Welcome!  We’re here to help you in your clinical and human research.

The mission of the Clinical Research Resources Office is to facilitate the design and conduct of ethical and scientifically valid clinical and human research by providing a range of services, resources and guidance to support BMC and BU Medical Campus clinical researchers in planning, submitting, conducting and analyzing their research. In fulfilling this mission, the CRRO strives to:

• Facilitate research  by providing guidance and tools that are relevant, focused, accessible, and current.
• Be responsive to needs of the BMC and BU Medical Campus clinical research community, the needs of research participants, and the changes in regulations and policies guiding human research.
• Centralize expertise and support  for the conduct of human research.
• Support & enhance the research workforce infrastructure to maximize quality of research.
• Foster research participant advocacy  by promotion of best practices to ensure the safe and ethical conduct of human research.

Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research

News provided by

Jun 04, 2024, 16:05 ET

Share this article

Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel Disease (IBD) CAPTURE and SIRQC Clinical Registries

BURLINGTON, Mass. , June 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA ) today announced it has been selected by the Crohn's & Colitis Foundation (the "Foundation") as its sample management services provider for two of its large-scale prospective research cohorts, CAPTURE IBD and IBD SIRQC, which investigate pediatric and surgical care for Crohn's disease and ulcerative colitis. Azenta will provide sample management services, including sample processing, analysis, logistics, and storage for these pivotal studies.

These studies are part of the Foundation's IBD Plexus ® research ecosystem and data platform that redefines how the research community studies Crohn's disease and ulcerative colitis to advance next-generation discoveries and novel therapies. The platform offers a rich research ecosystem for academic and life science researchers, providing prospective, longitudinal, and well-phenotyped data linked to biosamples to accelerate answering high-impact, patient-prioritized questions, and drive a revolutionary approach toward faster cures.

CAPTURE IBD (Cohort for Pediatric Translational and Clinical Research in Inflammatory Bowel Disease) is a multi-center, longitudinal study designed to advance precision medicine in pediatric IBD. CAPTURE is looking to enroll several thousand pediatric patients at 12 participating sites in the United States .

IBD SIRQC (Surgical Innovation, Research, and Quality Collaborative) is the Foundation's first-ever surgical research initiative designed as a longitudinal surgical cohort that will track long-term surgery outcomes including post-procedure complications and disease recurrence. SIRQC is looking to enroll 5,000 patients at 9 participating sites in the United States .

"The integration of novel pediatric and surgical data and biosamples into the IBD Plexus platform is critical to advance understanding of the complexity of IBD and develop precision medicine strategies," said Angela Dobes , Senior Vice President, IBD Plexus, Crohn's & Colitis Foundation. "We selected Azenta to support our CAPTURE and SIRQC research initiatives because of their high-quality, centralized sample management services and strong customer support. We look forward to continuing the partnership."

"Azenta is delighted to be expanding our relationship with the Crohn's & Colitis Foundation by supporting these critical studies that have the potential to accelerate breakthroughs for the Crohn's and ulcerative colitis community," said Kathi Shea , Vice President and General Manager of Sample and Repository Services at Azenta. "Our support of the Foundation goes back many years supporting clinical trial samples using our core storage and GENEWIZ Multiomics & Synthesis Solutions. We are proud to have been selected to support this prestigious organization."

About Crohn's &Colitis Foundation

The Crohn's & Colitis Foundation is the leading nonprofit organization focused on both research and patient support for inflammatory bowel disease (IBD), with the mission of curing Crohn's disease and ulcerative colitis and improving the quality of life for the millions of Americans living with IBD. The Foundation's work is dramatically accelerating the research process, while also providing extensive educational and support resources for patients and their families, medical professionals, and the public.

To learn more about the IBD Plexus® program, visit https://www.crohnscolitisfoundation.org/research/plexus

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA ) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey and B Medical Systems.

Azenta is headquartered in Burlington, Massachusetts , with operations in North America, Europe and Asia. For more information, please visit  www.azenta.com .

INVESTOR CONTACTS: Yvonne Perron Vice President, Financial Planning & Analysis, and Investor Relations [email protected]

Sherry Dinsmore [email protected]

Azenta's use of third-party trademarks and brands are for identification only and does not imply affiliation or endorsement. All trademarks used herein are the property of their respective owners.

SOURCE Azenta

Modal title

Also from this source.

Azenta to Participate in the Jefferies Global Healthcare Conference

Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Global Healthcare Conference in New York, NY,...

Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK

Azenta, Inc. (Nasdaq: AZTA) today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ...

Health Care & Hospitals

Medical Pharmaceuticals

Computer & Electronics